2658-6533Research Results in Biomedicine2658-653310.18413/2313-8955-2016-2-3-34-40771Archive categoriesRATIONALE FOR DEVELOPMENT OF THE COMPOSITION AND TECHNOLOGIES OF A COMPOUND PREPARATION FOR THE TREATMENT OF UROLITHIASISRATIONALE FOR DEVELOPMENT OF THE COMPOSITION AND TECHNOLOGIES OF A COMPOUND PREPARATION FOR THE TREATMENT OF UROLITHIASISZhilyakovaElena T.ZhilyakovaElena T.ezhilyakova@bsu.edu.ruZhuravlevaEvgeneya V.ZhuravlevaEvgeneya V.NovikovaMarina Yu.NovikovaMarina Yu.mnovikova@bsu.edu.ru20162300

Since ancient times, kidney stone disease has been the most common condition characterized by the formation of calculi (stones) in the cavities of the kidneys and bladder. Over the past few years there was a 25.8% increase in the number of visits of patients with this disease to the doctor (Apolikhin O.I., 2011), indicating that there is a trend of increasing the incidence of urolithiasis. The treatment of urolithiasis involves the use of specific drugs. In this regard, the study of the range of drugs registered in Russia, as well as the drugs which are not currently registered in Russia, but have a broad application in the treatment of kidney stones and gout is important worldwide. The aim of this research is to study a complex technology of creating an effective and safe drug for the treatment of urolithiasis. Content analysis was used as the method of the study, which implies a processing of information in order to detect or measure different facts and trends. The study revealed that the most commonly used drugs are allopurinol, Adenurik, Dezurik, the therapeutic effect of which is determined by different mechanisms of action aimed at reducing the production of uric acid and its concentration in the blood and urine.

Since ancient times, kidney stone disease has been the most common condition characterized by the formation of calculi (stones) in the cavities of the kidneys and bladder. Over the past few years there was a 25.8% increase in the number of visits of patients with this disease to the doctor (Apolikhin O.I., 2011), indicating that there is a trend of increasing the incidence of urolithiasis. The treatment of urolithiasis involves the use of specific drugs. In this regard, the study of the range of drugs registered in Russia, as well as the drugs which are not currently registered in Russia, but have a broad application in the treatment of kidney stones and gout is important worldwide. The aim of this research is to study a complex technology of creating an effective and safe drug for the treatment of urolithiasis. Content analysis was used as the method of the study, which implies a processing of information in order to detect or measure different facts and trends. The study revealed that the most commonly used drugs are allopurinol, Adenurik, Dezurik, the therapeutic effect of which is determined by different mechanisms of action aimed at reducing the production of uric acid and its concentration in the blood and urine.

hyperuricaemiaurolithiasisgouthyperuricaemiaurolithiasisgoutСписок литературыAllopurinol, Encyclopedia of Medicines. The Register of Medicines in Russia URL: http://www.rlsnet.ru/tn_index_id_4137.htm (date of access: May 20, 2016).Allopurinol. Vidal Drug Reference Book. URL: http://www.vidal.ru/drugs/allopurinol__18035 (date of access: May 20, 2016).Allopurinol-Aegis. Vidal Drug Reference Book. URL: http://www.vidal.ru/drugs/allopurinol-egis__2345 (date of access: May 20, 2016).Andrushkevich V.V. Biochemical Parameters of Blood, their Reference Values, and the Causes of Changes in the Level of Serum, 2.3. uric acid. Novosibirsk 2006 URL: http://www.labdiagnostic.ru/docs/specialists/bioxim_pokazat.shtml (date of access: May 20, 2016).Benzbromaron. The Drug Database. URL: http://www.regmed.ru/db/InnWork.aspx (date of access: May 20, 2016).Dezurik. Encyclopedia of Medicines. Register of Medicines in Russia. URL: http://www.rlsnet.ru/tn_index_id_3781.htm (date of access: May 20, 2016).Morbidity by Main Disease Classes in 2000-2014. URL: http://www.gks.ru/wps/wcm/connect/rosstat_main/rosstat/ru/statistics/population/healthcare/# (date of access: May 20, 2016).The History of Gout. URL: http://rheumo.ru/preodolenie/gout/233-istoriya-podagry.html (date of access: May 20, 2016).Urolithiasis. Yesterday, Today, Tomorrow. URL: http://mchs-uro/mkb-segodnja  (date of access: May 20, 2016).Gout: the Etiology and Pathogenesis to Diagnosis and Rational Pharmacotherapy/ Atakhanova L.E., Tsurko V.V., Buleeva I.M., Boiko I.N., Zheleznov S.P., Ivanova T.B.  Modern Rheumatology.  2007. №1. Pp. 13-18.Selitskaya O.V., Borisenko N.A.  Modern Views of Gout // Siberian Health Review 2009. № 2. Vol. 50. URL: http://cyberleninka.ru/article/n/sovremennye-predstavleniya-o-podagre (date of access: May 20, 2016)Sukhikh Zh.L., Shtonda M.V., Petrov S.A., Vorobieva E.P. Gout: Modern Aspects of Diagnosis and Treatment // International Reviews: Clinical Practice and Health. 2014. №5 (11). URL: http://cyberleninka.ru/article/n/podagra-sovremennye-aspekty-diagnostiki-i-lecheniya (date of access: May 20, 2016)Shuba N.M. Gout – a Multimorbid Pathology / Ukrainsky Revmatologіchny Zhurnal. - 2015. -№ 1 (59). URL: http://www.rheumatology.kiev.ua/article/7687/podagra-multimorbidnaya-patologiya (date of access: May 20, 2016)Epidemiology of Urolithiasis in Different regions of the Russian Federation / Apolihin O.I., Sivkov A. V., Solntseva T.V., Komarova V.A. // Bulletin of Medical Internet Conferences. 2011. №3 (Volume 1). Pp. 167-176.Summary of Product Characteristics Adenuric 80 mg film-coated tablets URL: http://www.medicines.ie/medicine/14607/SPC/Adenuric+80+mg+film-coated+tablets/ (date of access: May 20, 2016)